Terms: = Thyroid cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM
145 results:
1. Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer.
Nakamoto S; Shien T; Iwamoto T; Kubo S; Yamamoto M; Yamashita T; Kuwahara C; Ikeda M
Sci Rep; 2024 Apr; 14(1):9869. PubMed ID: 38684839
[TBL] [Abstract] [Full Text] [Related]
2. Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study.
Riis T; Bonnema SJ; Brix TH; Folkestad L
Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38367342
[TBL] [Abstract] [Full Text] [Related]
3. Construction and validation of a prognostic nutritional index-based nomogram for predicting pathological complete response in breast cancer: a two-center study of 1,170 patients.
Qu F; Luo Y; Peng Y; Yu H; Sun L; Liu S; Zeng X
Front Immunol; 2023; 14():1335546. PubMed ID: 38274836
[TBL] [Abstract] [Full Text] [Related]
4. The association between serum selenium levels and pathological features of papillary thyroid cancer in 284 patients.
Ge S; Zhao J; Yao J; Fu H; Tian Y; Shan Y; Sun M; Feng J; Dong J; Liao L
Front Endocrinol (Lausanne); 2023; 14():1242250. PubMed ID: 38027150
[TBL] [Abstract] [Full Text] [Related]
5. The association between thyroid and breast cancers: a bidirectional mendelian randomization study.
Liu J; Liang L
Front Endocrinol (Lausanne); 2023; 14():1185497. PubMed ID: 37955011
[TBL] [Abstract] [Full Text] [Related]
6. Associations between BMI in youth and site-specific cancer in men-A cohort study with register linkage.
Onerup A; Mehlig K; Af Geijerstam A; Ekblom-Bak E; Kuhn HG; Lissner L; Rosengren A; Börjesson M; Åberg M
Obesity (Silver Spring); 2024 Feb; 32(2):376-389. PubMed ID: 37927128
[TBL] [Abstract] [Full Text] [Related]
7. Factors Associated with Survival in Anaplastic thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
Jannin A; Giudici F; de la Fouchardière C; Al Ghuzlan A; Wassermann J; Chougnet CN; Drui D; Godbert Y; Ilouz F; Bardet S; Zanetta S; Roudaut N; Batisse Lignier M; Groussin L; Klein M; Zerdoud S; Lamartina L; Baudin E; Decaussin-Petrucci M; Leteurtre E; Borson Chazot F; Do Cao C; Borget I; Hadoux J;
Thyroid; 2023 Oct; 33(10):1190-1200. PubMed ID: 37855745
[No Abstract] [Full Text] [Related]
8. Cigarette smoking and thyroid cancer risk: A Mendelian randomization study.
Jiang H; Li Y; Shen J; Lin H; Fan S; Qiu R; He J; Lin E; Chen L
Cancer Med; 2023 Oct; 12(19):19866-19873. PubMed ID: 37746910
[TBL] [Abstract] [Full Text] [Related]
9. Clinical value of grayscale ultrasound combined with real-time shear wave elastography nomogram in risk prediction of thyroid cancer.
Ren T; Jiang M; Wu J; Zhang F; Zhang C
BMC Med Imaging; 2023 Sep; 23(1):123. PubMed ID: 37700270
[TBL] [Abstract] [Full Text] [Related]
10. Facilitation of Definitive cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With thyroid Nodules.
Fu G; Chazen RS; Monteiro E; Vescan A; Freeman JL; Witterick IJ; MacMillan C
JAMA Netw Open; 2023 Jul; 6(7):e2323500. PubMed ID: 37505499
[TBL] [Abstract] [Full Text] [Related]
11. TERT Promoter Mutations Frequency Across Race, Sex, and cancer Type.
El Zarif T; Machaalani M; Nawfal R; Nassar AH; Xie W; Choueiri TK; Pomerantz M
Oncologist; 2024 Jan; 29(1):8-14. PubMed ID: 37462445
[TBL] [Abstract] [Full Text] [Related]
12.
Fukuda K; Seki N; Yasudome R; Mitsueda R; Asai S; Kato M; Idichi T; Kurahara H; Ohtsuka T
Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239355
[TBL] [Abstract] [Full Text] [Related]
13. Integration of Artificial Intelligence Decision Aids to Reduce Workload and Enhance Efficiency in thyroid Nodule Management.
Tong WJ; Wu SH; Cheng MQ; Huang H; Liang JY; Li CQ; Guo HL; He DN; Liu YH; Xiao H; Hu HT; Ruan SM; Li MD; Lu MD; Wang W
JAMA Netw Open; 2023 May; 6(5):e2313674. PubMed ID: 37191957
[TBL] [Abstract] [Full Text] [Related]
14. Expecting the unexpected: incidental findings at a level 1 trauma center.
Kolbeinsson HM; Dandamudi S; Gira J; Krech L; Pounders S; Fisk C; Wright GP; Chapman AJ; Chadwick C
Emerg Radiol; 2023 Jun; 30(3):343-349. PubMed ID: 37186087
[TBL] [Abstract] [Full Text] [Related]
15. The diagnostic efficacy and inappropriate biopsy rate of ACR TI-RADS and ATA guidelines for thyroid nodules in children and adolescents.
Li G; Zhang B; Liu J; Xiong Y
Front Endocrinol (Lausanne); 2023; 14():1052945. PubMed ID: 37051202
[TBL] [Abstract] [Full Text] [Related]
16. Linear association between radioactive iodine dose and second primary malignancy risk in thyroid cancer.
Kim KJ; Kim KJ; Choi J; Kim NH; Kim SG
J Natl Cancer Inst; 2023 Jun; 115(6):695-702. PubMed ID: 36821433
[TBL] [Abstract] [Full Text] [Related]
17. [Validation of calculation method for dose distribution around radioactive iodine-125 particles based on AAPM TG43 report].
Tian SQ; Wang JJ; Ji Z; Jiang YL; Qiu B; Fan JH; Sun HT
Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(3):199-204. PubMed ID: 36649991
[No Abstract] [Full Text] [Related]
18. [Association of extranodal extension and lymph node ratio with radioactive iodine-refractory papillary thyroid cancer].
Luo ZY; Qin JW; Fang JG; Zheng C; Gong WB; Hei H
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3856-3861. PubMed ID: 36540923
[No Abstract] [Full Text] [Related]
19. Analysis of Delayed Surgery and Clinical Outcomes in Intermediate- and High-risk Papillary thyroid cancer.
Zhou H; Wu J; Shi L; Wang Y; Liu B
J Clin Endocrinol Metab; 2022 Nov; 107(12):3389-3397. PubMed ID: 36056633
[TBL] [Abstract] [Full Text] [Related]
20. Patterns and temporal trends in the incidence of childhood and adolescence cancer in Cyprus 1998-2017: A population-based study from the Cyprus Paediatric Oncology Registry.
Loizou L; Demetriou A; Erdmann F; Borkhardt A; Brozou T; Sharp L; McNally R
Cancer Epidemiol; 2022 Oct; 80():102239. PubMed ID: 35994888
[TBL] [Abstract] [Full Text] [Related]
[Next]
